Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer
書誌事項
- 公開日
- 2005-07
- 権利情報
-
- http://www.springer.com/tdm
- DOI
-
- 10.1038/sj.bjc.6602687
- 公開者
- Springer Science and Business Media LLC
この論文をさがす
収録刊行物
-
- British Journal of Cancer
-
British Journal of Cancer 93 (2), 195-199, 2005-07
Springer Science and Business Media LLC
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1361981470166848640
-
- ISSN
- 15321827
- 00070920
- http://id.crossref.org/issn/00070920
-
- データソース種別
-
- Crossref